INTRODUCTION: This study aimed to identify whether microbial invasion of the amniotic cavity and/or intra-amniotic inflammation in women with late preterm prelabor rupture of membranes (PPROM) was associated with changes in concentrations of soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF) and its ratio in maternal serum, and whether placental features consistent with maternal vascular malperfusion further affect their concentrations. MATERIAL AND METHODS: This historical study included 154 women with singleton pregnancies complicated by PPROM between gestational ages 34+0 and 36+6 weeks. Transabdominal amniocentesis was performed as part of standard clinical management to evaluate the intra-amniotic environment. Women were categorized into two subgroups based on the presence of microorganisms and/or their nucleic acids in amniotic fluid (determined by culturing and molecular biology method) and intra-amniotic inflammation (by amniotic fluid interleukin-6 concentration evaluation): (1) those with the presence of microorganisms and/or inflammation (at least one present) and (2) those with negative amniotic fluid for infection/inflammation (absence of both). Concentrations of sFlt-1 and PlGF were assessed using the Elecsys® sFlt-1 and Elecsys® PlGF immunoassays and converted into multiples of medians. RESULTS: Women with the presence of microorganisms and/or inflammation in amniotic fluid had lower serum concentrations of sFlt-1 and sFlt-1/PlGF ratios and higher concentrations of PlGF compared with those with negative amniotic fluid. (sFlt-1: presence: median 1.0 multiples of the median (MoM), vs negative: median: 1.5 MoM, P = 0.003; PlGF: presence: median 0.7 MoM, vs negative: median 0.4 MoM, P = 0.02; sFlt-1/PlGF: presence: median 8.9 vs negative 25.0, P = 0.001). Higher serum concentrations of sFlt-1 and sFlt-1/PlGF ratios as well as lower concentrations of PlGF were found in the subsets of women with maternal vascular malperfusion than in those without maternal vascular malperfusion. CONCLUSIONS: Among women experiencing late PPROM, angiogenic imbalance in maternal serum is primarily observed in those without both microbial invasion of the amniotic cavity and intra-amniotic inflammation. Additionally, there is an association between angiogenic imbalance and the presence of maternal vascular malperfusion.

Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic

Department of Clinical Science Intervention and Technology Division of Obstetrics and Gynecology Karolinska Institute Stockholm Sweden

Department of Genetics and Bioinformatics Domain of Health Data and Digitalization Institute of Public Health Oslo Norway

Department of Obstetrics and Gynecology Hospital Most Usti nad Labem Czech Republic

Department of Obstetrics and Gynecology Institute of Clinical Science Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

Department of Obstetrics and Gynecology Region Västra Götaland Sahlgrenska University Hospital Gothenburg Sweden

Department of Pathology School of Medicine Detroit Wayne State University Detroit Michigan USA

Fingerland Institute of Pathology University Hospital Hradec Kralove Charles University Faculty of Medicine in Hradec Kralove Hradec Kralove Czech Republic

Institute of Clinical Biochemistry and Diagnostics University Hospital Hradec Kralove Charles University Faculty of Medicine in Hradec Kralove Hradec Kralove Czech Republic

Nordic IVF Eugin group Solna Sweden

Zobrazit více v PubMed

Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol. 2003;101:178‐193. PubMed

Mercer BM. Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstet Gynecol Clin N Am. 2005;32:411‐428. PubMed

Menon R, Behnia F, Polettini J, Richardson LS. Novel pathways of inflammation in human fetal membranes associated with preterm birth and preterm pre‐labor rupture of the membranes. Semin Immunopathol. 2020;42:431‐450. PubMed PMC

Romero R, Miranda J, Chaemsaithong P, et al. Sterile and microbial‐associated intra‐amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2015;28:1394‐1409. PubMed PMC

Menon R, Richardson LS. Preterm prelabor rupture of the membranes: a disease of the fetal membranes. Semin Perinatol. 2017;41:409‐419. PubMed PMC

Kim CJ, Romero R, Kusanovic JP, et al. The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol. 2010;23:1000‐1011. PubMed PMC

Kumar D, Schatz F, Moore RM, et al. The effects of thrombin and cytokines upon the biomechanics and remodeling of isolated amnion membrane, in vitro. Placenta. 2011;32:206‐213. PubMed PMC

Romero R, Jung E, Chaiworapongsa T, et al. Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology. Am J Obstet Gynecol. 2022;227(615):e1‐e25. PubMed PMC

Savasan ZA, Romero R, Chaiworapongsa T, et al. Evidence in support of a role for anti‐angiogenic factors in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2010;23:828‐841. PubMed PMC

Rodriguez‐Trujillo A, Cobo T, Vives I, et al. Gestational age is more important for short‐term neonatal outcome than microbial invasion of the amniotic cavity or intra‐amniotic inflammation in preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand. 2016;95:926‐933. PubMed

Kacerovsky M, Musilova I, Andrys C, et al. Prelabor rupture of membranes between 34 and 37 weeks: the intraamniotic inflammatory response and neonatal outcomes. Am J Obstet Gynecol. 2014;210(325):e1‐e10. PubMed

Kim CJ, Romero R, Chaemsaithong P, Kim JS. Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol. 2015;213:S53‐S69. PubMed PMC

Morris JM, Roberts CL, Bowen JR, et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet. 2016;387:444‐452. PubMed

Musilova I, Kutova R, Pliskova L, et al. Intraamniotic inflammation in women with preterm Prelabor rupture of membranes. PLoS One. 2015;10:e0133929. PubMed PMC

Romero R, Salafia CM, Athanassiadis AP, et al. The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology. Am J Obstet Gynecol. 1992;166:1382‐1388. PubMed

Kacerovsky M, Musilova I, Hornychova H, et al. Bedside assessment of amniotic fluid interleukin‐6 in preterm prelabor rupture of membranes. Am J Obstet Gynecol. 2014;211(385):e1‐e9. PubMed

Kacerovsky M, Romero R, Stepan M, et al. Antibiotic administration reduces the rate of intraamniotic inflammation in preterm prelabor rupture of the membranes. Am J Obstet Gynecol. 2020;223(114):e1‐e20. PubMed PMC

Lee J, Kim JS, Park JW, et al. Chronic chorioamnionitis is the most common placental lesion in late preterm birth. Placenta. 2013;34:681‐689. PubMed

Nijman TA, van Vliet EO, Benders MJ, et al. Placental histology in spontaneous and indicated preterm birth: a case control study. Placenta. 2016;48:56‐62. PubMed

Tsiakkas A, Duvdevani N, Wright A, Wright D, Nicolaides KH. Serum soluble fms‐like tyrosine kinase‐1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol. 2015;45:584‐590. PubMed

Tsiakkas A, Duvdevani N, Wright A, Wright D, Nicolaides KH. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol. 2015;45:591‐598. PubMed

Musilova I, Andrys C, Holeckova M, et al. Interleukin‐6 measured using the automated electrochemiluminescence immunoassay method for the identification of intra‐amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2020;33:1919‐1926. PubMed

Fouhy F, Deane J, Rea MC, et al. The effects of freezing on faecal microbiota as determined using MiSeq sequencing and culture‐based investigations. PLoS One. 2015;10:e0119355. PubMed PMC

Kacerovsky M, Pliskova L, Bolehovska R, et al. Lactobacilli‐dominated cervical microbiota in women with preterm prelabor rupture of membranes. Pediatr Res. 2020;87:952‐960. PubMed

Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus Statement. Arch Pathol Lab Med. 2016;140:698‐713. PubMed

Romero R, Miranda J, Chaiworapongsa T, et al. Prevalence and clinical significance of sterile intra‐amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol. 2014;72:458‐474. PubMed PMC

Romero R, Miranda J, Chaiworapongsa T, et al. Sterile intra‐amniotic inflammation in asymptomatic patients with a sonographic short cervix: prevalence and clinical significance. J Matern Fetal Neonatal Med. 2015;28:1343‐1359. PubMed PMC

Daneshmand SS, Chmait RH, Moore TR, Bogic L. Preterm premature rupture of membranes: vascular endothelial growth factor and its association with histologic chorioamnionitis. Am J Obstet Gynecol. 2002;187:1131‐1136. PubMed

Lockwood CJ, Krikun G, Rahman M, Caze R, Buchwalder L, Schatz F. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states. Semin Thromb Hemost. 2007;33:111‐117. PubMed

Rajakumar A, Michael HM, Rajakumar PA, et al. Extra‐placental expression of vascular endothelial growth factor receptor‐1, (Flt‐1) and soluble Flt‐1 (sFlt‐1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta. 2005;26:563‐573. PubMed

Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta. 1997;18:657‐665. PubMed

Chiu CPH, Feng Q, Chaemsaithong P, et al. Prediction of spontaneous preterm birth and preterm prelabor rupture of membranes using maternal factors, obstetric history and biomarkers of placental function at 11‐13 weeks. Ultrasound Obstet Gynecol. 2022;60:192‐199. PubMed

Espinoza J, Chaiworapongsa T, Romero R, et al. Unexplained fetal death: another anti‐angiogenic state. J Matern Fetal Neonatal Med. 2007;20:495‐507. PubMed PMC

Korzeniewski SJ, Romero R, Chaiworapongsa T, et al. Maternal plasma angiogenic index‐1 (placental growth factor/soluble vascular endothelial growth factor receptor‐1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case‐cohort study. Am J Obstet Gynecol. 2016;214(629):e1‐e17. PubMed PMC

Kim YM, Chaiworapongsa T, Gomez R, et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol. 2002;187:1137‐1142. PubMed

Kim YM, Bujold E, Chaiworapongsa T, et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2003;189:1063‐1069. PubMed

Rowson S, Reddy M, Rolnik DL, Da Silva CF, Palmer KR. Stability of placental growth factor, soluble fms‐like tyrosine kinase 1, and soluble fms‐like tyrosine kinase 1 e15a in human serum and plasma. Placenta. 2019;86:1‐3. PubMed

Law LW, Sahota DS, Chan LW, Chen M, Lau TK, Leung TY. Effect of long‐term storage on placental growth factor and fms‐like tyrosine kinase 1 measurements in samples from pregnant women. J Matern Fetal Neonatal Med. 2010;23:1475‐1480. PubMed